Bibliografía del artículo
1. Brown HL, Abernathy MP. Cytomegalovirus infection. Seminars in Perinatology 22(4):260-266, 1998.
2. Pannuti CS, Kallás EG, Muccioli C, Roland RK, Ferreira EC, Bueno MHS, Do Canto CLM, Vilas Boas LS, Belfort R. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis. Am J of Ophthalmology 122:847-852, 1996.
3. Costa SCB. Infecção por citomegalovírus (CMV): Epidemiologia, diagnóstico e tratamento. Revista Brasileira de Clínica e Terapêutica 25(1):18-28, 1999.
4. Demmler GJ. Cytomegalovirus infection: Back to the future or no more elephants? Clin Infec Dis 43:1152-1153, 2006.
5. Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86(7):2815-2820, 1995.
6. Bonon SHA, Menoni SMF, Rossi CL et al. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients. J Infec 50:130-137, 2005.
7. Lkungman P, Perez-Bercoff L, Jonson J et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica 91(1):78-83, 2006.
8. Bonon SHA, Rossi CL, De Souza CA et al. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients. Rev Inst Med Trop S Paulo 48(5):275-278, 2006.
9. Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L. Successful modification of a pp65 antigenemia-based treatment strategy for prevention of CMV disease in allogeneic marrow transplant recipients. Blood 93:1781-1782, 1999 (letter).
10. Ljungman P, Plotkin SA. Workshop on CMV disease: Definitions, clinical severity scores, and new syndromes. Scand J Infect Dis Suppl 99:87-89, 1995.
11. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 118:44-57, 2002.